FemHealth Focus: Investment opportunities

The women’s health market is estimated to have a global value of $48.2bn. Although currently largely concentrated in the US, Europe is fast catching up.

Women’s health holds immense potential, yet glaring health inequalities between the sexes persist. Research published by McKinsey and the World Economic Forum in 2024 identifies disparities across the entire care pathway, from prevention to treatment and follow-up care. And the gaps extend beyond care delivery, encompassing the research, data, and investment that underpin it.

At the end of last year, in Manchester, Mills & Reeve hosted a roundtable focused on investment, and how the city and the wider North West is championing women’s health businesses through funding, partnerships and support.

Whilst the outlook might seem gloomy, part one of the series outlines the key discussions of that afternoon and focuses on the opportunities and barriers to financial investment.

The report below features contributions from Bionow's Exec Director of Business Development, Stella James!

Read the report here